Biopharma Leadership Conclave 2021 - Day1: Oligonucleotides, Gene Therapy, mRNA Vaccines

You will be updated on latest technological launches, analytical challenges & workflow solutions & latest applications through live talks, panel discussions from industries experts & Agilent Biopharma specialists.

Day 1: Oligonucleotides, Gene Therapy, mRNA Vaccines:

2.30 p.m. (IST) Setting the Stage

• Mr. Shailendra Chavan (Agilent Technologies)

2:40 p.m. (IST) mRNA Therapeutics: Journey from Concept to Clinical Reality

• Dr.Priyaranjan Pattanaik (Head, NBE Services, Aurigene Pharmaceutical Services)

3:10 p.m. (IST) Analytical Challenges And An Assessment Of Orthogonal Techniques In The Characterization Of Therapeutic Oligonucleotides

• Dr. Guru S Madugundu (Lead Scientist, Syngene International)

3:30 p.m. (IST) Oligonucleotides: Separation and Purification

• Ms. Paramjeet Khandpur (Agilent Technologies)

3:40 p.m. (IST) Rapid Analysis of mRNA 5’ Capping with High Resolution LC MS

• Dr. Brian Liau (Solution Development Scientist , Agilent Technologies, Singapore)

3:55 p.m. (IST) Considerations for ensuring Quality of Cell and Gene Therapy products

• Dr. Shashwati Basak (Biopharma Professional & Independent Consultant)

4:20 p.m. (IST) Analytical Tools for Characterizing Cell and Gene Therapy Products

• Dr. Smruti M. Phadnis (Biopharma Marketing Manager, Cell and Gene Therapy, Agilent Technologies United States)

4:40 p.m. (IST) onwards Panel Discussion

• Moderated by Dr. Vadi Bhat and Mr. Chirag Khambhati